Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
International Journal of Medical Sciences
|
November 7, 2019
Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus
Nan Nwe Win, Tatsuo Kanda, Masahiro Ogawa, et al.
Oncotarget
|
February 14, 2018
Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature
Yuki Haga, Tatsuo Kanda, Shin Yasui, et al.
Oncotarget
|
April 18, 2018
Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events
Tatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
Oncotarget
|
March 17, 2018
Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis
Tatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
International Journal of Molecular Sciences
|
April 26, 2017
Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
Tatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
Environmental Science and Pollution Research International
|
December 19, 2012
Polychlorinated biphenyl (118) activates osteoclasts and induces bone resorption in goldfish
Koji Yachiguchi, Noriko Matsumoto, Yuki Haga, et al.
Liver Cancer
|
October 1, 2020
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma
Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study
Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, et al.
Investigational New Drugs
|
June 8, 2019
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
Sadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa, et al.
BMC Gastroenterology
|
April 2, 2023
Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice
Sae Yumita, Sadahisa Ogasawara, Miyuki Nakagawa, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
International Journal of Medical Sciences
|
November 7, 2019
Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus
Nan Nwe Win, Tatsuo Kanda, Masahiro Ogawa, et al.
Oncotarget
|
February 14, 2018
Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature
Yuki Haga, Tatsuo Kanda, Shin Yasui, et al.
Oncotarget
|
April 18, 2018
Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events
Tatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
Oncotarget
|
March 17, 2018
Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis
Tatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
International Journal of Molecular Sciences
|
April 26, 2017
Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
Tatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
Environmental Science and Pollution Research International
|
December 19, 2012
Polychlorinated biphenyl (118) activates osteoclasts and induces bone resorption in goldfish
Koji Yachiguchi, Noriko Matsumoto, Yuki Haga, et al.
Liver Cancer
|
October 1, 2020
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma
Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study
Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, et al.
Investigational New Drugs
|
June 8, 2019
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
Sadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa, et al.
BMC Gastroenterology
|
April 2, 2023
Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice
Sae Yumita, Sadahisa Ogasawara, Miyuki Nakagawa, et al.
Page
of 8